Cambridge Investment Research Advisors
CL icon

Cambridge Investment Research Advisors’s Colgate-Palmolive CL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.85M Sell
103,874
-17,272
-14% -$1.54M 0.02% 663
2025
Q4 		$9.57M Sell
121,146
-31,279
-21% -$2.45M 0.03% 604
2025
Q3 		$12.2M Buy
152,425
+33,243
+28% +$2.84M 0.03% 498
2025
Q2 		$10.8M Sell
119,182
-1,056
-0.9% -$96.4K 0.03% 511
2025
Q1 		$11.3M Sell
120,238
-5,053
-4% -$452K 0.04% 462
2024
Q4 		$11.4M Sell
125,291
-72,628
-37% -$6.93M 0.04% 440
2024
Q3 		$20.5M Buy
197,919
+92,409
+88% +$9.42M 0.07% 276
2024
Q2 		$10.2M Sell
105,510
-8,979
-8% -$828K 0.04% 455
2024
Q1 		$10.3M Sell
114,489
-70,413
-38% -$5.97M 0.04% 453
2023
Q4 		$14.7M Buy
184,902
+10,589
+6% +$796K 0.06% 296
2023
Q3 		$12.4M Sell
174,313
-19,015
-10% -$1.42M 0.06% 314
2023
Q2 		$14.9M Sell
193,328
-14,310
-7% -$1.11M 0.07% 275
2023
Q1 		$15.6M Buy
207,638
+111,705
+116% +$8.31M 0.08% 258
2022
Q4 		$7.56M Buy
95,933
+1,290
+1% +$96.7K 0.04% 437
2022
Q3 		$6.65M Sell
94,643
-174
-0.2% -$13.6K 0.04% 449
2022
Q2 		$7.6M Buy
94,817
+3,045
+3% +$238K 0.04% 420
2022
Q1 		$6.96M Buy
91,772
+802
+0.9% +$63.5K 0.03% 504
2021
Q4 		$7.76M Sell
90,970
-1,358
-1% -$106K 0.03% 473
2021
Q3 		$6.98M Sell
92,328
-2,550
-3% -$202K 0.03% 477
2021
Q2 		$7.72M Sell
94,878
-3,394
-3% -$278K 0.04% 457
2021
Q1 		$7.75M Buy
98,272
+7,705
+9% +$604K 0.04% 407
2020
Q4 		$7.74M Sell
90,567
-1,229
-1% -$102K 0.05% 375
2020
Q3 		$7.08M Buy
91,796
+6,772
+8% +$516K 0.05% 356
2020
Q2 		$6.23M Sell
85,024
-3,827
-4% -$272K 0.05% 375
2020
Q1 		$5.9M Buy
88,851
+219
+0.2% +$15.4K 0.06% 311
2019
Q4 		$6.1M Buy
88,632
+7,369
+9% +$502K 0.05% 390
2019
Q3 		$5.97M Buy
81,263
+1,446
+2% +$105K 0.05% 348
2019
Q2 		$5.72M Sell
79,817
-7,669
-9% -$544K 0.05% 348
2019
Q1 		$6M Buy
87,486
+62
+0.1% +$4K 0.06% 313
2018
Q4 		$5.2M Sell
87,424
-102
-0.1% -$6.38K 0.06% 309
2018
Q3 		$5.86M Buy
87,526
+1,683
+2% +$112K 0.06% 324
2018
Q2 		$5.56M Sell
85,843
-6,742
-7% -$441K 0.06% 301
2018
Q1 		$6.64M Buy
92,585
+11,336
+14% +$816K 0.07% 253
2017
Q4 		$6.13M Buy
81,249
+11,036
+16% +$806K 0.07% 263
2017
Q3 		$5.12M Buy
70,213
+5,570
+9% +$401K 0.07% 278
2017
Q2 		$4.79M Sell
64,643
-4,636
-7% -$344K 0.07% 264
2017
Q1 		$5.07M Buy
69,279
+3,637
+6% +$255K 0.09% 220
2016
Q4 		$4.3M Buy
65,642
+630
+1% +$43.2K 0.08% 233
2016
Q3 		$4.82M Buy
65,012
+1,336
+2% +$98.8K 0.09% 210
2016
Q2 		$4.66M Buy
63,676
+17,477
+38% +$1.24M 0.1% 190
2016
Q1 		$3.26M Sell
46,199
-13,769
-23% -$916K 0.07% 256
2015
Q4 		$4M Sell
59,968
-2,083
-3% -$139K 0.09% 209
2015
Q3 		$3.94M Buy
62,051
+13,066
+27% +$854K 0.11% 181
2015
Q2 		$3.2M Buy
48,985
+2,006
+4% +$136K 0.09% 222
2015
Q1 		$3.26M Sell
46,979
-3,803
-7% -$263K 0.09% 217
2014
Q4 		$3.51M Buy
50,782
+81
+0.2% +$5.47K 0.11% 177
2014
Q3 		$3.31M Sell
50,701
-6,114
-11% -$403K 0.1% 197
2014
Q2 		$3.87M Buy
56,815
+3,074
+6% +$206K 0.14% 145
2014
Q1 		$3.49M Buy
53,741
+1,375
+3% +$86.6K 0.13% 145
2013
Q4 		$3.42M Buy
52,366
+1,081
+2% +$69.2K 0.14% 144
2013
Q3 		$3.04M Buy
51,285
+10,111
+25% +$599K 0.13% 156
2013
Q2 		$2.36M Buy
+41,174
New +$2.44M 0.12% 168

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cambridge Investment Research Advisors's CL Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Colgate-Palmolive (CL) stake by 14% in Q1 2026, selling an estimated $1.54M and leaving 103,874 shares worth $8.85M. The position accounts for 0.02% of the portfolio, ranked #663.

Cambridge Investment Research Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.5M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Cambridge Investment Research Advisors held 103,874 shares of Colgate-Palmolive worth $8.85M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 17,272 Colgate-Palmolive shares in Q1 2026, an estimated $1.54M.
  • Colgate-Palmolive made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #663 holding.
  • Cambridge Investment Research Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Cambridge Investment Research Advisors's Colgate-Palmolive position peaked at $20.5M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.